During the past decade, Southeastern Pennsylvania Medical Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southeastern Pennsylvania Medical Institute" are "Major Depressive Disorder" (1 trials), "Osteoarthritis" (1 trials) and "Osteoarthritis of the Knee" (1 trials). Many other conditions were trialed in "Southeastern Pennsylvania Medical Institute" in a lesser frequency.

Most popular intervention types in "Southeastern Pennsylvania Medical Institute" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Desvenlafaxine Succinate" (1 trials), "Diclofenac Sodium Gel" (1 trials), "Diclofenac topical sodium gel 1%" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Pennsylvania Medical Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Southeastern Pennsylvania Medical Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Southeastern Pennsylvania Medical Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Pennsylvania Medical Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".